Treatment of Catatonia When Lorazepam and Diazepam Are Unavailable
When lorazepam and diazepam are unavailable for treating catatonia with a medical cause, use alternative benzodiazepines (midazolam or clonazepam), atypical antipsychotics (olanzapine, risperidone, or aripiprazole), or zolpidem as viable alternatives, while simultaneously treating the underlying medical condition and considering electroconvulsive therapy (ECT) if the patient fails to respond.
Alternative Benzodiazepines
Midazolam
- Start with 2.5-5 mg subcutaneously or intravenously every 1-2 hours as needed 1, 2
- Can be administered intramuscularly if IV access is unavailable
- If needed frequently (more than twice daily), consider continuous subcutaneous infusion starting at 10 mg over 24 hours
- Reduce dose to 5 mg over 24 hours if estimated glomerular filtration rate (eGFR) is <30 mL/min 1
- Critical caveat: Higher risk of respiratory depression and over-sedation compared to lorazepam, particularly in elderly or frail patients 3, 2
- Use lower doses (0.5-1 mg) in older patients, those with COPD, or when co-administered with antipsychotics 2
Clonazepam
- Alternative parenteral benzodiazepine option 3
- Oral route: 1-4 mg/day for short-term use 4
- Longer half-life than lorazepam, which increases risk of accumulation in elderly patients 3
Atypical Antipsychotics
When benzodiazepines are completely unavailable or contraindicated, atypical antipsychotics can be effective for catatonia:
Olanzapine (Preferred Atypical)
- Oral wafer: 2.5-5 mg initially, maximum 10 mg in 24 hours 3
- Intramuscular: 2.5 mg initially, can give 2.5 mg increments to maximum 7.5 mg, at no closer than 30-minute intervals 3
- Advantages: Available in rapidly dissolving formulation, less likely to cause extrapyramidal symptoms 2
- Important warning: Do NOT give parenteral benzodiazepines until at least 2 hours after olanzapine administration due to risk of respiratory depression 3
- Monitor for hypotension, bradycardia, confusion, and ataxia 3
- Evidence from case reports shows successful treatment of catatonia with olanzapine combined with amantadine when lorazepam failed 5
Risperidone
- Oral quicklet: 0.5-1 mg initially, maximum 2 mg daily 3, 2
- Available as orally disintegrating tablet, practical when patient cooperation is limited 3
- Monitor for hypotension, sedation, ataxia 3
- Increased risk of extrapyramidal symptoms if dose exceeds 6 mg/24 hours 2
Aripiprazole
- 5 mg orally or intramuscularly (immediate-release) initially 2
- Give every 24 hours if scheduled dosing required
- Less likely to cause extrapyramidal symptoms 2
- May cause headache, agitation, anxiety, insomnia 2
Haloperidol (Use with Caution)
- 0.25-0.5 mg intramuscularly initially, maximum 2 mg daily 3
- For delirium with catatonic features: 0.5-1 mg orally at night and every 2 hours when required 1
- Higher risk of extrapyramidal symptoms and dystonia compared to atypical antipsychotics 3
- Use lowest effective dose in elderly patients
Zolpidem (Emerging Alternative)
Zolpidem 10 mg orally (range 5-45 mg) has shown an 84.8% response rate in catatonia across 79 published cases 6:
- Mean time to response: 30.2 minutes 6
- Can be used as both diagnostic challenge test (85.7% response) and treatment (86.1% response) 6
- Particularly effective when used alone (85.7% response) or with benzodiazepines (81.3% response) 6
- Higher response rate in women (88.6%) compared to men (64.7%) 6
- Case reports demonstrate success in post-traumatic stress disorder with catatonia refractory to benzodiazepines 7
Combination Strategies
When monotherapy fails:
- Lorazepam + memantine + dantrolene (one-time dose) successfully treated malignant catatonia in one case where ECT was unavailable 8
- Olanzapine + amantadine effective for lorazepam-refractory catatonia 5
- Consider adding weak NMDA receptor antagonists (amantadine, memantine) to antipsychotics 5
Electroconvulsive Therapy
ECT remains the definitive treatment for catatonia, particularly when:
- Pharmacological interventions fail after 48-72 hours
- Life-threatening symptoms present (refusal to eat/drink, severe suicidality, malignant catatonia) 9
- Neuroleptic malignant syndrome develops 9
- Catatonia is severe or malignant (mortality rate >50% if untreated) 8
For lorazepam-refractory catatonia, 95% of patients fully recovered with either lorazepam continuation or ECT 10
Critical Monitoring Requirements
Regardless of agent chosen:
- Maintain patent airway with ventilatory support immediately available 11
- Monitor vital signs continuously, especially with parenteral agents 3, 4
- Assess for respiratory depression, over-sedation, falls risk 3
- Ensure adequate hydration and nutrition 12
- Treat underlying medical cause simultaneously (hypoxia, urinary retention, constipation, metabolic derangements, infections) 1, 11
Dosing Principles
- Start low and go slow, particularly in elderly patients 3
- Use PRN (as needed) dosing initially, convert to scheduled dosing only if symptoms persist 3, 2
- Prescribe specific doses rather than dose ranges 3
- Review and reduce doses daily as symptoms improve 3, 2
- In elderly patients, reduce all doses by 50% 3
Common Pitfalls to Avoid
- Do not use IM diazepam - not recommended for acute sedation 3
- Avoid IV sedation in elderly patients with agitation 3
- Do not combine olanzapine with parenteral benzodiazepines within 2 hours - risk of respiratory depression 3
- Do not overlook treatable medical causes - catatonia may result from hypoglycemia, hyponatremia, infections, or other metabolic derangements 11
- Do not delay ECT if patient deteriorates or fails to respond to pharmacotherapy within 48-72 hours 9, 8, 10